page-header

Category: News

EQUIRVIS™, a unique ophthalmic solution developed exclusively for VET-CXL™

The continuous improvement in product development by Vision Engineering Italy has led to EQUIRVIS™, a high concentration riboflavin ophthalmic solution…

VETUVIR, the revolution in veterinary ophthalmology

Vetuvir is the first UV-A medical device developed for exclusive use in veterinary medicine for the treatment of corneal infections…

VISION ENGINEERING ITALY, the success of a user driven medtech product engineering Company. How VET-CXL® was born.

Vision Engineering Italy is a medtech company focused to research & development of breakthrough technological solutions to unmet needs in…

VET-CXL®: how does it work?

The VET-CXL® protocol consists of irradiating the cornea with high UV-A power density, 30 mW/cm2, after soaking the tissue with…

VET-CXL® protocol for treating corneal infections in veterinary medicine

Corneal phototherapy has opened up a new therapeutic area in veterinary medicine. Thanks to the Vetuvir® medical device, developed by…

Corneal infections in veterinary medicine: a serious health problem caused by antibiotic resistance

Corneal infections, such as infectious keratitis and corneal ulcers, represent the most common ocular diseases in dogs and cats; they…